Showing results (51-60 of 76) with videos related to
Sort By:
Pageof 8
Circulation Journal : Official Journal of the Japanese Circulation Society|July 23, 2023
Residual Coronary Risk Factors Associated With Long-Term Clinical Outcomes in Patients With Coronary Artery Disease Treated With High- vs. Low-Dose Statin Therapy - REAL-CAD SubstudyTakumi Higuma, Yoshihiro J Akashi, Yoshihiro Fukumoto, et al.Journal of Atherosclerosis and Thrombosis|August 13, 2023
Association between Non-Lipid Residual Risk Factors and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Pitavastatin: An Observation from the REAL-CAD StudyKiwamu Kamiya, Makoto Takei, Toshiyuki Nagai, et al.Trials|January 18, 2014
The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled studyTatsuo Hosoya, Kenjiro Kimura, Sadayoshi Itoh, et al.The Journal of Clinical Investigation|December 22, 2007
The GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrityYuka Ichikawa-Shindo, Takayuki Sakurai, Akiko Kamiyoshi, et al.Frontiers in Medicine|July 29, 2021
Association Between Kidney Function Decline and Baseline TNFR Levels or Change Ratio in TNFR by Febuxostat Chiefly in Non-diabetic CKD Patients With Asymptomatic HyperuricemiaTomohito Gohda, Naotake Yanagisawa, Maki Murakoshi, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 5, 2018
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized TrialKenjiro Kimura, Tatsuo Hosoya, Shunya Uchida, et al.JACC. Advances|August 12, 2024
Significance of Persistent Inflammation in Patients With Chronic Coronary Syndrome: Insights From the REAL-CAD StudyHiroshi Iwata, Katsumi Miyauchi, Ryo Naito, et al.International Heart Journal|March 6, 2018
Rationale and Design of Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy with Pitavastatin in Coronary Artery Disease (REAL-CAD) TrialKatsumi Miyauchi, Takeshi Kimura, Hiroaki Shimokawa, et al.Geriatrics & Gerontology International|March 23, 2012
Non-high-density lipoprotein cholesterol: an important predictor of stroke and diabetes-related mortality in Japanese elderly diabetic patientsAtsushi Araki, Satoshi Iimuro, Takashi Sakurai, et al.Geriatrics & Gerontology International|March 23, 2012
Long-term multiple risk factor interventions in Japanese elderly diabetic patients: the Japanese Elderly Diabetes Intervention Trial--study design, baseline characteristics and effects of interventionAtsushi Araki, Satoshi Iimuro, Takashi Sakurai, et al.Pageof 8